Literature DB >> 20964632

Sensitive measurement of unmethylated repeat DNA sequences by end-specific PCR.

Keith N Rand1, Peter L Molloy.   

Abstract

We describe a new method that is well-suited for the determination of the methylation level of repetitive sequences such as human Alu elements. We have applied the method to the analysis of cell and tissue DNAs and expect it to have wide utility in studies of DNA methylation in cancer and other disease states, in monitoring response to epigenetic cancer therapies and in epidemiological studies. Only 1 ng DNA is needed for a duplex, one-tube real-time PCR in which methylation level and the amount of input DNA are concurrently measured. The relative cutting by the methylation-sensitive enzyme BstUI is compared with that of the methylation-insensitive enzyme DraI to give a measure of DNA methylation. The method depends upon the use of 5'-tailed, 3'-blocked oligonucleotides called facilitator oligonucleotides (Foligos). Only cut DNAs with specific matching sequences at their 3' ends can copy the tails of the Foligos and thus become tagged and available for subsequent PCR. Both the tagging and PCR are carried out by the same enzyme, Taq DNA polymerase. Because amplification only occurs if suitable ends have been generated in the target DNA, we have called this method end-specific PCR (ESPCR). ESPCR avoids the bisulfite treatment step that is usually required to measure methylation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20964632     DOI: 10.2144/000113494

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  8 in total

1.  Sensitive quantitative analysis of murine LINE1 DNA methylation using high resolution melt analysis.

Authors:  Michelle Newman; Benjamin J Blyth; Damian J Hussey; Daniel Jardine; Pamela J Sykes; Rebecca J Ormsby
Journal:  Epigenetics       Date:  2012-01-01       Impact factor: 4.528

2.  Tissue and cancer-specific expression of DIEXF is epigenetically mediated by an Alu repeat.

Authors:  Berta Martín; Stella Pappa; Anna Díez-Villanueva; Izaskun Mallona; Joaquín Custodio; María José Barrero; Miguel A Peinado; Mireia Jordà
Journal:  Epigenetics       Date:  2020-02-11       Impact factor: 4.528

3.  Effect of prenatal DHA supplementation on the infant epigenome: results from a randomized controlled trial.

Authors:  Susan J van Dijk; Jing Zhou; Timothy J Peters; Michael Buckley; Brodie Sutcliffe; Yalchin Oytam; Robert A Gibson; Andrew McPhee; Lisa N Yelland; Maria Makrides; Peter L Molloy; Beverly S Muhlhausler
Journal:  Clin Epigenetics       Date:  2016-11-04       Impact factor: 6.551

4.  The epigenetic landscape of Alu repeats delineates the structural and functional genomic architecture of colon cancer cells.

Authors:  Mireia Jordà; Anna Díez-Villanueva; Izaskun Mallona; Berta Martín; Sergi Lois; Víctor Barrera; Manel Esteller; Tanya Vavouri; Miguel A Peinado
Journal:  Genome Res       Date:  2016-12-20       Impact factor: 9.043

5.  A novel restriction endonuclease GlaI for rapid and highly sensitive detection of DNA methylation coupled with isothermal exponential amplification reaction.

Authors:  Yueying Sun; Yuanyuan Sun; Weimin Tian; Chenghui Liu; Kejian Gao; Zhengping Li
Journal:  Chem Sci       Date:  2017-12-11       Impact factor: 9.825

6.  Aberrant DNA methylation of M1-macrophage genes in coronary artery disease.

Authors:  Chetan Bakshi; Rajesh Vijayvergiya; Veena Dhawan
Journal:  Sci Rep       Date:  2019-02-05       Impact factor: 4.379

Review 7.  DNA Methylation Cancer Biomarkers: Translation to the Clinic.

Authors:  Warwick J Locke; Dominic Guanzon; Chenkai Ma; Yi Jin Liew; Konsta R Duesing; Kim Y C Fung; Jason P Ross
Journal:  Front Genet       Date:  2019-11-14       Impact factor: 4.599

8.  Sensitive and selective amplification of methylated DNA sequences using helper-dependent chain reaction in combination with a methylation-dependent restriction enzymes.

Authors:  Keith N Rand; Graeme P Young; Thu Ho; Peter L Molloy
Journal:  Nucleic Acids Res       Date:  2012-09-10       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.